896 related articles for article (PubMed ID: 20138833)
21. Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region.
Miura M; Miura Y; Sonoyama W; Yamaza T; Gronthos S; Shi S
Oral Dis; 2006 Nov; 12(6):514-22. PubMed ID: 17054762
[TBL] [Abstract][Full Text] [Related]
22. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
23. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy.
Zimmet JM; Hare JM
Basic Res Cardiol; 2005 Nov; 100(6):471-81. PubMed ID: 16237508
[TBL] [Abstract][Full Text] [Related]
24. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
25. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
[TBL] [Abstract][Full Text] [Related]
26. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
27. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.
Bernardo ME; Emons JA; Karperien M; Nauta AJ; Willemze R; Roelofs H; Romeo S; Marchini A; Rappold GA; Vukicevic S; Locatelli F; Fibbe WE
Connect Tissue Res; 2007; 48(3):132-40. PubMed ID: 17522996
[TBL] [Abstract][Full Text] [Related]
28. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
29. In vivo osteoinductive effect and in vitro isolation and cultivation bone marrow mesenchymal stem cells.
Redzić A; Smajilagić A; Aljicević M; Berberović L
Coll Antropol; 2010 Dec; 34(4):1405-9. PubMed ID: 21874729
[TBL] [Abstract][Full Text] [Related]
30. Stem cells: potential therapy for age-related diseases.
Kassem M
Ann N Y Acad Sci; 2006 May; 1067():436-42. PubMed ID: 16804023
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells for cardiac regenerative therapy.
Schuleri KH; Boyle AJ; Hare JM
Handb Exp Pharmacol; 2007; (180):195-218. PubMed ID: 17554510
[TBL] [Abstract][Full Text] [Related]
33. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model.
Wan C; He Q; Li G
J Orthop Res; 2006 Apr; 24(4):610-8. PubMed ID: 16514623
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells.
Pal R; Hanwate M; Jan M; Totey S
J Tissue Eng Regen Med; 2009 Mar; 3(3):163-74. PubMed ID: 19229888
[TBL] [Abstract][Full Text] [Related]
36. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs).
Wan C; He Q; McCaigue M; Marsh D; Li G
J Orthop Res; 2006 Jan; 24(1):21-8. PubMed ID: 16419965
[TBL] [Abstract][Full Text] [Related]
37. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.
Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X
Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478
[TBL] [Abstract][Full Text] [Related]
38. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart.
Furlani D; Li W; Pittermann E; Klopsch C; Wang L; Knopp A; Jungebluth P; Thedinga E; Havenstein C; Westien I; Ugurlucan M; Li RK; Ma N; Steinhoff G
Cell Transplant; 2009; 18(3):319-31. PubMed ID: 19558780
[TBL] [Abstract][Full Text] [Related]
39. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
Gnecchi M; Melo LG
Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
